Editorial
Published on 27 Sep 2023
Editorial: Global excellence in inflammatory diseases: Latin America 2021
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2023.1278212
- 1,296 views
Type at least 3 characters
34,140 articles
Original Research
Published on 27 Sep 2023
Single cell transcriptomics reveals recent CD8T cell receptor signaling in patients with coronary artery disease
in T Cell Biology
Frontiers in Immunology
doi 10.3389/fimmu.2023.1239148
- 5,748 views
- 5 citations
Review
Published on 27 Sep 2023
Immune interaction between SARS-CoV-2 and Mycobacterium tuberculosis
in Microbial Immunology
Frontiers in Immunology
doi 10.3389/fimmu.2023.1254206
- 4,630 views
- 15 citations
Original Research
Published on 27 Sep 2023
Organ complications after CD19 CAR T-cell therapy for large B cell lymphoma: a retrospective study from the EBMT transplant complications and lymphoma working party
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1252811
- 3,758 views
- 5 citations
Original Research
Published on 27 Sep 2023
Hypomethylation-induced regulatory programs in T cells unveiled by transcriptomic analyses
in Alloimmunity and Transplantation
Frontiers in Immunology
doi 10.3389/fimmu.2023.1235661
- 3,345 views
- 3 citations
Original Research
Published on 27 Sep 2023
Leishmania braziliensis exosomes activate human macrophages to produce proinflammatory mediators
in Microbial Immunology
Frontiers in Immunology
doi 10.3389/fimmu.2023.1256425
- 4,093 views
- 5 citations
Original Research
Published on 27 Sep 2023
Antibodies to coagulase of Staphylococcus aureus crossreact to Efb and reveal different binding of shared fibrinogen binding repeats
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1221108
- 2,587 views
- 2 citations
Original Research
Published on 27 Sep 2023
Divergent molecular events underlying initial T-cell commitment in human prenatal and postnatal thymus
in T Cell Biology
Frontiers in Immunology
doi 10.3389/fimmu.2023.1240859
- 2,987 views
Original Research
Published on 27 Sep 2023
Piezoelectric-based bioactive zinc oxide-cellulose acetate electrospun mats for efficient wound healing: an in vitro insight
in Alloimmunity and Transplantation
Frontiers in Immunology
doi 10.3389/fimmu.2023.1245343
- 4,739 views
- 10 citations
Original Research
Published on 27 Sep 2023
Patient-reported outcomes in patients with primary immunodeficiency diseases in Japan: baseline results from a prospective observational study
in Primary Immunodeficiencies
Frontiers in Immunology
doi 10.3389/fimmu.2023.1244250
- 4,067 views
- 5 citations
Review
Published on 27 Sep 2023
Combination of multiple omics techniques for a personalized therapy or treatment selection
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1258013
- 2,877 views
- 4 citations
Review
Published on 27 Sep 2023
Neutrophil extracellular traps and long COVID
in Viral Immunology
Frontiers in Immunology
doi 10.3389/fimmu.2023.1254310
- 12,899 views
- 16 citations
Original Research
Published on 27 Sep 2023
Altered plasma metabolites and inflammatory networks in HIV-1 infected patients with different immunological responses after long-term antiretroviral therapy
in Viral Immunology
Frontiers in Immunology
doi 10.3389/fimmu.2023.1254155
- 4,261 views
- 11 citations
Original Research
Published on 27 Sep 2023
Pediatric population (aged 3-11 years) received primary inactivated SARS-CoV-2 vaccination prior to infection exhibiting robust humoral immune response following infected with Omicron variant: a study conducted in Beijing
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1269665
- 1,702 views
- 3 citations
Original Research
Published on 27 Sep 2023
The causal relationship between gut microbiota and inflammatory dermatoses: a Mendelian randomization study
in Autoimmune and Autoinflammatory Disorders: Autoinflammatory Disorders
Frontiers in Immunology
doi 10.3389/fimmu.2023.1231848
- 13,171 views
- 19 citations
General Commentary
Published on 27 Sep 2023
Commentary: Targeting chemoattractant chemokine (C–C motif) ligand 2 derived from astrocytes is a promising therapeutic approach in the treatment of neuromyelitis optica spectrum disorders
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2023.1279782
- 1,400 views